CD19/CD20 CAR-T cell therapy

CD19 and CD20 targeted chimeric antigen receptor T cells · Peking University People's Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19/CD20 CAR-T cell therapy, covering 2026-01-15 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: An Open and Dose-escalation Early Clinical Study of CD19 and CD20 CAR-T Cell Therapy for Relapsed or Refractory Aggressive B-cell Lymphoma [EARLY_Phase 1]

See pricing